CN110179875A - 一种预防治疗肝胃肠癌的中药组合物 - Google Patents
一种预防治疗肝胃肠癌的中药组合物 Download PDFInfo
- Publication number
- CN110179875A CN110179875A CN201910296612.2A CN201910296612A CN110179875A CN 110179875 A CN110179875 A CN 110179875A CN 201910296612 A CN201910296612 A CN 201910296612A CN 110179875 A CN110179875 A CN 110179875A
- Authority
- CN
- China
- Prior art keywords
- medicine composition
- chinese
- chinese medicine
- human primary
- gastrointestinal cancers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 61
- 210000004185 liver Anatomy 0.000 title claims abstract description 52
- 239000000203 mixture Substances 0.000 title claims abstract description 37
- 206010017993 Gastrointestinal neoplasms Diseases 0.000 title claims abstract description 21
- 238000011321 prophylaxis Methods 0.000 title claims abstract description 17
- 235000015277 pork Nutrition 0.000 claims abstract description 25
- 235000008216 herbs Nutrition 0.000 claims abstract description 23
- 244000179560 Prunella vulgaris Species 0.000 claims abstract description 18
- 235000010674 Prunella vulgaris Nutrition 0.000 claims abstract description 18
- 235000009436 Actinidia deliciosa Nutrition 0.000 claims abstract description 14
- 239000004615 ingredient Substances 0.000 claims abstract description 11
- 229940079593 drug Drugs 0.000 claims abstract description 8
- 239000002674 ointment Substances 0.000 claims description 8
- 239000002245 particle Substances 0.000 claims description 8
- 239000006187 pill Substances 0.000 claims description 8
- 241000205585 Aquilegia canadensis Species 0.000 claims description 6
- 235000010254 Jasminum officinale Nutrition 0.000 claims description 4
- 244000298697 Actinidia deliciosa Species 0.000 claims 3
- 240000005385 Jasminum sambac Species 0.000 claims 1
- 235000014258 Polygonum bistorta Nutrition 0.000 claims 1
- 240000003186 Stachytarpheta cayennensis Species 0.000 claims 1
- 235000009233 Stachytarpheta cayennensis Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 14
- 239000000463 material Substances 0.000 abstract description 14
- 241000219068 Actinidia Species 0.000 abstract description 11
- 230000002265 prevention Effects 0.000 abstract description 11
- 201000009030 Carcinoma Diseases 0.000 abstract description 5
- 239000008280 blood Substances 0.000 abstract description 5
- 210000004369 blood Anatomy 0.000 abstract description 5
- 230000002440 hepatic effect Effects 0.000 abstract description 5
- 230000001225 therapeutic effect Effects 0.000 abstract description 5
- 206010013911 Dysgeusia Diseases 0.000 abstract description 3
- 210000000496 pancreas Anatomy 0.000 abstract description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 2
- 229930185803 charantin Natural products 0.000 abstract description 2
- 239000008103 glucose Substances 0.000 abstract description 2
- 241000411851 herbal medicine Species 0.000 description 13
- 206010028980 Neoplasm Diseases 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- 238000005457 optimization Methods 0.000 description 6
- 241000207840 Jasminum Species 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 238000001784 detoxification Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 4
- 201000007270 liver cancer Diseases 0.000 description 4
- 208000014018 liver neoplasm Diseases 0.000 description 4
- 208000025747 Rheumatic disease Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 238000002512 chemotherapy Methods 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000000552 rheumatic effect Effects 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010006002 Bone pain Diseases 0.000 description 2
- 208000002513 Flank pain Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 210000002683 foot Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 244000302512 Momordica charantia Species 0.000 description 1
- 235000009811 Momordica charantia Nutrition 0.000 description 1
- 235000009812 Momordica cochinchinensis Nutrition 0.000 description 1
- 235000018365 Momordica dioica Nutrition 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 240000001659 Oldenlandia diffusa Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000010224 hepatic metabolism Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000004377 improving vision Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 201000000349 mediastinal cancer Diseases 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/407—Liver; Hepatocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Developmental Biology & Embryology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Nutrition Science (AREA)
- Immunology (AREA)
- Virology (AREA)
- Physiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种预防治疗肝胃肠癌的中药组合物，包括半枝莲、白花蛇草、藤梨梗、夏枯草、野菜籽和猪肝；该中药组合物各组分如下：半枝莲30‑60g，白花蛇草30‑60g，藤梨梗30‑60g，夏枯草30‑50g，野菜籽50‑150g和猪肝100‑200g；本发明以野菜籽和猪肝为基料，添加半枝莲、白花蛇草和夏枯草，用于治疗预防肝癌疗效良好，本发明进一步添加藤梨梗，提高治疗预防肝癌疗效的同时治疗预防胃肠癌疗效显著；本发明中野菜籽选用野木瓜籽，性味苦寒，它含有一些天然的苦瓜苷，有效平衡血糖也能提高胰岛功效能，还能修复破损的组织细胞，有利于提高治疗预防肝胃肠癌疗效，本发明中该中药组合物还包括辅佐成分，进一步提高药物的治疗预防肝癌疗效同时改善药物的口感。
Description
技术领域
本发明属于抗癌药物技术领域，具体为一种预防治疗肝胃肠癌的中药组合物。
背景技术
中药主要由植物药（根、茎、叶、果）、动物药（内脏、皮、骨、器官等）和矿物药组成。因植物药占中药的大多数，所以中药也称中草药。
中国各地使用的中药已达5000种左右，把各种药材相配伍而形成的方剂，更是数不胜数。经过几千年的研究，形成了一门独立的科学——本草学。现在中国各医学院校都开设了天然药物这门课，所讲述的内容就是通称的中草药。
中草药在预防治疗一些癌症时，具有突出的疗效，然而传统中草药组合物，不能满足目前多发的肝胃肠癌治疗要求，疗效不理想，为此我们推出了一种预防治疗肝胃肠癌的中药组合物。
发明内容
本发明的目的在于：为了解决预防治疗肝胃肠癌的中草药组合物匮乏的技术问题，提供一种预防治疗肝胃肠癌的中药组合物。
本发明采用的技术方案如下：
一种预防治疗肝胃肠癌的中药组合物，该中药组合物包括半枝莲、白花蛇草、藤梨梗、夏枯草、野菜籽和猪肝。
该中药组合物各组分如下：半枝莲30-60g，白花蛇草30-60g，藤梨梗30-60g，夏枯草30-50g，野菜籽50-150g和猪肝100-200g。
其中，作为优化，该中药组合物各组分具体如下：包括半枝莲30g、白花蛇草50g、藤梨梗40g、夏枯草40g、野菜籽150g和猪肝150g。
其中，作为优化，所述野菜籽选用野木瓜籽。
其中，作为优化，该中药组合物还包括辅佐成分，所述辅佐成分包括甘草，金银花和茉莉花。
其中，作为优化，该中药组合物制成供内服的药丸。
其中，作为优化，该中药组合物制成供内服冲饮的颗粒或粉剂。
其中，作为优化，该中药组合物制成用于敷贴的药膏。
药理分析：
野菜籽：野菜籽中野木瓜籽性味苦寒，能除邪，也能解乏无力，它含有一些天然的苦瓜苷，平时人们食用以后可以平衡血糖也能提高胰岛功效能，还能修复破损的组织细胞，另外人们食用可以降血糖也能降血脂，对人类的三高症状有很好的预防作用。
猪肝：补肝明目，养血。用于血虚萎黄、夜盲、目赤、浮肿、脚气等症；肝含有丰富的铁、磷，它是造血不可缺少的原料， 猪肝中富含蛋白质、卵磷脂和微量元素，有利于儿童的智力发育和 身体发育。猪肝中含有丰富的维生素A，常吃猪肝，可逐渐消除眼科病症。据近代医学研究发现，猪肝具有多种抗癌物质，如维生素C、硒等，而且肝脏还具有较强的抑癌能力，含有抗疲劳的特殊物质。肝脏是贮存养料的器官，同时又是解毒器官，不断发挥其解毒作用，经肝脏代谢后，有毒物质和解毒产物可以随胆汁的分泌而排出体外，所以，正常的肝脏本身是无毒的，可以放心食用；
半枝莲：有清热解毒，活血化瘀，消肿止痛，抗癌之功效；治阑尾炎、肝炎、胃痛、早期肝癌、肺癌、子宫颈癌、乳腺炎等；外用治痛疖疗，跌打肿痛等症。
白花蛇草：清热解毒、消痛散结、利尿除湿；尤善治疗各种类型炎症。在临床实践中，发现白花蛇舌草若配伍得当，可治疗多种疾病。
夏枯草：清火散结、治疗瘰疬，一般可以用夏枯草熬成夏枯草膏服用，夏枯草还可以清肝明目、降血压，对纵隔的肿瘤，有一定的抗肿瘤作用。
藤梨梗：主治清热解毒，清热利湿，防肿瘤抗癌，祛风除湿，利尿止血，解毒消肿，消化不良、呕吐、风湿痹痛、风湿骨痛、消化道癌肿、消化道肿瘤、痈疡疮疖、风湿骨痛及黄疸等症。
综上所述，由于采用了上述技术方案，本发明的有益效果是：
1、本发明以野菜籽和猪肝为基料，添加半枝莲、白花蛇草和夏枯草，用于治疗预防肝癌疗效良好，本发明进一步添加藤梨梗，提高治疗预防肝癌疗效的同时治疗预防胃肠癌疗效显著。
2、本发明中野菜籽选用野木瓜籽，性味苦寒，能除邪，也能解乏无力，它含有一些天然的苦瓜苷，有效平衡血糖也能提高胰岛功效能，还能修复破损的组织细胞，有利于提高治疗预防肝胃肠癌疗效。
3、本发明中该中药组合物还包括辅佐成分，所述辅佐成分包括甘草，金银花和茉莉花，金银花和茉莉花具有清肝明目疗效；进一步提高药物的治疗预防肝癌疗效，另外甘草改善药物的口感。
4、本发明中，该中药组合物可以制成供内服的药丸，或者供内服冲饮的颗粒或粉剂；或者制成用于敷贴的药膏，方便不同服用要求。
具体实施方式
为了使本发明的目的、技术方案及优点更加清楚明白，以下对本 发明进行进一步详细说明。应当理解，此处所描述的具体实施例仅用 以解释本发明，并不用于限定本发明。
实施例一，该中药组合物各组分具体如下：包括半枝莲20g、白花蛇草20g、藤梨梗20g、夏枯草30g、野菜籽60g和猪肝100g；其中野菜籽为野木瓜籽；
将上述中草药类药物原料清洗，将猪肝洗净去毒后煮熟后切块放入中草药类药物原料中混合，粉碎研磨随后分别制成药丸、颗粒和用于敷贴的药膏。
实施例二，该中药组合物各组分具体如下：包括半枝莲40g、白花蛇草30g、藤梨梗20g、夏枯草30g、野菜籽100g和猪肝150g；
将上述中草药类药物原料清洗，将猪肝洗净去毒后煮熟后切块放入中草药类药物原料中混合，粉碎研磨随后分别制成药丸、颗粒和用于敷贴的药膏。
实施例三，该中药组合物各组分具体如下：包括半枝莲30g、白花蛇草50g、藤梨梗40g、夏枯草40g、野菜籽150g和猪肝150g；
将上述中草药类药物原料清洗，将猪肝洗净去毒后煮熟后切块放入中草药类药物原料中混合，粉碎研磨随后分别制成药丸、颗粒和用于敷贴的药膏。
实施例四，该中药组合物各组分具体如下：包括半枝莲30g、白花蛇草50g、藤梨梗40g、夏枯草40g、野菜籽150g和猪肝150g；并添加辅佐成分，所述辅佐成分包括甘草20g，金银花30g和茉莉花30g；
将上述中草药类药物原料清洗，将猪肝洗净去毒后煮熟后切块放入中草药类药物原料中混合，粉碎研磨随后分别制成药丸、颗粒和用于敷贴的药膏。
实施例五，该中药组合物各组分具体如下：包括半枝莲30g、白花蛇草50g、夏枯草40g、野菜籽150g和猪肝150g；并添加辅佐成分，所述辅佐成分包括甘草20g，金银花30g和茉莉花30g；
将上述中草药类药物原料清洗，将猪肝洗净去毒后煮熟后切块放入中草药类药物原料中混合，粉碎研磨随后分别制成药丸、颗粒和用于敷贴的药膏。
临床应用实例：
1、陈某某，女，48岁，患者缘于一年前出现肝肋部疼痛，经医 院检查确诊肝癌，随即进行化疗治疗随后出现腹部和腰部疼痛明显， 伴有频繁恶心、呕吐。于是停止化疗，在家人的建议下试用本发明实 施例四的中药组合物半年以后，患者各种疼痛及不良反应消失，生活 质量得到很大提高。后继服用治疗，多次复查腹部CT病情基本稳定。
2、牛某某，女，68岁，面黄肌瘦，脚软乏力，经医院病理诊断 为：肝癌。因年事已高，放弃化疗，在朋友的建议下试用本发明实施 例四的中药组合物治疗一年多，症状大部分渐次好转，精神得到极大 改善，经医院检查病情得到控制，目前仍继续使用该中药。
3、刘某某，男，57岁，长期腹部饱胀不适或隐痛、泛酸、嗳气、 恶心，经医院确诊为胃肠癌，病人接受一段时间化疗后，承受不了副 作用，恶心呕吐，在朋友建议下接受本发明实施例四的中药组合物治 疗，半年以后，症状有所缓解，精神较好。继续接受治疗，病人情况 缓解明显，经医院检查病情得到控制，目前仍继续使用该中药。
以上所述仅为本发明的较佳实施例而已，并不用以限制本发明，凡在本发明的精神和原则之内所作的任何修改、等同替换和改进等，均应包含在本发明的保护范围之内。
Claims (8)
1.一种预防治疗肝胃肠癌的中药组合物，其特征在于：该中药组合物包括半枝莲、白花蛇草、藤梨梗、夏枯草、野菜籽和猪肝。
2.如权利要求1所述的一种预防治疗肝胃肠癌的中药组合物，其特征在于：该中药组合物各组分如下：半枝莲30-60g，白花蛇草30-60g，藤梨梗30-60g，夏枯草30-50g，野菜籽50-150g和猪肝100-200g。
3.如权利要求2所述的一种预防治疗肝胃肠癌的中药组合物，其特征在于：该中药组合物组分包括半枝莲30g、白花蛇草50g、藤梨梗40g、夏枯草40g、野菜籽150g和猪肝150g。
4.如权利要求3所述的一种预防治疗肝胃肠癌的中药组合物，其特征在于：所述野菜籽选用野木瓜籽。
5.如权利要求1-4任一所述的一种预防治疗肝胃肠癌的中药组合物，其特征在于：该中药组合物还包括辅佐成分，所述辅佐成分包括甘草，金银花和茉莉花。
6.如权利要求5所述的一种预防治疗肝胃肠癌的中药组合物，其特征在于：该中药组合物制成供内服的药丸。
7.如权利要求5所述的一种预防治疗肝胃肠癌的中药组合物，其特征在于：该中药组合物制成供内服冲饮的颗粒或粉剂。
8.如权利要求5所述的一种预防治疗肝胃肠癌的中药组合物，其特征在于：该中药组合物制成用于敷贴的药膏。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910296612.2A CN110179875A (zh) | 2019-04-13 | 2019-04-13 | 一种预防治疗肝胃肠癌的中药组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910296612.2A CN110179875A (zh) | 2019-04-13 | 2019-04-13 | 一种预防治疗肝胃肠癌的中药组合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110179875A true CN110179875A (zh) | 2019-08-30 |
Family
ID=67714189
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910296612.2A Pending CN110179875A (zh) | 2019-04-13 | 2019-04-13 | 一种预防治疗肝胃肠癌的中药组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110179875A (zh) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1183290A (zh) * | 1996-11-26 | 1998-06-03 | 孙黛娟 | 一种用于治疗癌症的抗癌灵药物 |
| CN1294009A (zh) * | 1999-10-28 | 2001-05-09 | 马金发 | 抗癌中药制剂及其置备方法 |
| CN104547151A (zh) * | 2015-01-27 | 2015-04-29 | 黑龙江中医药大学 | 一种中药提取物及制备方法 |
| CN108143796A (zh) * | 2018-02-28 | 2018-06-12 | 西安交通大学 | 一种中药复方在制备抗肿瘤药物中的应用 |
-
2019
- 2019-04-13 CN CN201910296612.2A patent/CN110179875A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1183290A (zh) * | 1996-11-26 | 1998-06-03 | 孙黛娟 | 一种用于治疗癌症的抗癌灵药物 |
| CN1294009A (zh) * | 1999-10-28 | 2001-05-09 | 马金发 | 抗癌中药制剂及其置备方法 |
| CN104547151A (zh) * | 2015-01-27 | 2015-04-29 | 黑龙江中医药大学 | 一种中药提取物及制备方法 |
| CN108143796A (zh) * | 2018-02-28 | 2018-06-12 | 西安交通大学 | 一种中药复方在制备抗肿瘤药物中的应用 |
Non-Patent Citations (1)
| Title |
|---|
| 宋卓 等: "扶正解毒法防治胃癌的理论基础及循证依据", 《中医杂志》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102068707B (zh) | 一种b超使用的中药助影剂及其制备方法 | |
| CN105166545A (zh) | 一种牛配合饲料及其制备方法 | |
| KR20130063074A (ko) | 당뇨병과 당뇨합병증의 혈당 혈압 저하작용 조성물 | |
| CN103431276A (zh) | 一种供炎性肠病患者食用的五谷杂粮全营养配方食品 | |
| CN103431260B (zh) | 供胃肠道吸收障碍、胰腺炎患者食用的五谷杂粮全营养配方食品 | |
| CN103989955A (zh) | 一种治疗胃、十二指肠溃疡、浅表性多发性胃溃疡、糜烂性胃溃疡的药物组合物 | |
| CN101239162B (zh) | 一种治疗胃病的中药组合物 | |
| CN107875365A (zh) | 一种治疗慢性肺源性心脏病的中药组合物及其制备方法 | |
| CN103798596B (zh) | 一种供心脑血管疾病患者食用的全营养配方食品 | |
| CN110179875A (zh) | 一种预防治疗肝胃肠癌的中药组合物 | |
| CN112076305A (zh) | 一种治疗人体代谢症候群及杀菌消炎的中药制内服外用原液合剂 | |
| CN106822852A (zh) | 治疗冠心病的药物组合物、其制备工艺及用途 | |
| CN109395045A (zh) | 一种治疗2型糖尿病湿热中阻证的清热化湿调糖丸及其制备方法 | |
| CN103431277B (zh) | 一种供创伤、手术患者食用的五谷杂粮全营养配方食品 | |
| CN107854662A (zh) | 一种治疗肝硬化腹水的中药制剂及其制备方法 | |
| CN102423414B (zh) | 治疗寒凝气滞胃痛的外用中药制剂 | |
| CN107854588A (zh) | 一种治疗脂肪肝的中药组合物及其制备方法 | |
| CN106309989A (zh) | 一种治疗尿毒症及其并发症的药物 | |
| CN106237245B (zh) | 一种治疗急慢性腹泻的中药组合物及其制剂和应用 | |
| CN101164595A (zh) | 一种治疗厌食症的中药 | |
| CN105214001B (zh) | 一种治疗高血压合并冠心病的中药组合物 | |
| CN104940777A (zh) | 一种治疗肝旺脾弱型经行泄泻的冲剂及其制备方法 | |
| CN103933368B (zh) | 用于治疗产后便秘的药物组合物及其制备方法 | |
| CN102652827B (zh) | 一种治疗癌症的药物和制备方法 | |
| CN116549520A (zh) | 一种气血双补、清肺止咳的中药组方、中药液和药物制剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190830 |
|
| RJ01 | Rejection of invention patent application after publication |